Abstract
We investigated the antileukemia effects and molecular mechanisms of apoptosis induction by simultaneous blockade of PI3K and mutant FLT3 in AML cells grown under hypoxia in co-cultures with bone marrow stromal cells. Combined treatment with selective class I PI3K inhibitor GDC-0941 and sorafenib reversed the protective effects of bone marrow stromal cells on FLT3-mutant AML cells in hypoxia, which was associated with downregulation of Pim-1 and Mcl-1 expression levels. These findings suggest that combined inhibition of PI3K and FLT3-ITD may constitute a targeted approach to eradicating chemoresistant AML cells sequestered in hypoxic bone marrow niches.
Original language | English (US) |
---|---|
Pages (from-to) | 45-58 |
Number of pages | 14 |
Journal | Cancer Letters |
Volume | 329 |
Issue number | 1 |
DOIs | |
State | Published - Feb 1 2013 |
Keywords
- Acute myeloid leukemia
- Bone marrow microenvironment
- GDC-0941
- Hypoxia
- Sorafenib
ASJC Scopus subject areas
- Oncology
- Cancer Research